Is APO or REGN cheaper?

On trailing earnings, REGN is cheaper: APO trades at a 40.08 P/E and REGN at 14.92.

Which has grown faster, APO or REGN?

Over the past five years, APO grew revenue faster — APO at a 37.15% CAGR versus REGN at 10.16%.

Does APO or REGN pay a bigger dividend?

APO yields 1.56% and REGN yields 0.59% based on trailing dividends and the latest price.

Is APO or REGN more profitable?

REGN runs the higher net margin — APO at 7.24% versus REGN at 29.65%.

Which has been the better investment, APO or REGN?

Over the past 10-year, APO delivered the higher annualized total return — APO at 29.59% versus REGN at 5.30%. Past performance doesn't predict future results.

Apollo Global Management, Inc. (APO) vs Regeneron Pharmaceuticals, Inc. (REGN)

APO leads on 8 of 14 compared metrics, though REGN is the cheaper stock.

A side-by-side comparison of Apollo Global Management, Inc. and Regeneron Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

APO

Apollo Global Management, Inc.

$79.41B

$133.88Financial Services

REGN

Regeneron Pharmaceuticals, Inc.

$62.98B

$612.14Healthcare

Total return — APO vs REGN

growth of $100 · last 15y

APO +657.4%REGN +1268.3%REGN compounded faster

APO REGN

APO vs REGN: by the numbers

•APO is the larger company ($79.41B vs $62.98B market cap).
•REGN trades at the lower earnings multiple (14.92 vs 40.08 P/E).
•REGN converts more revenue to profit (29.65% vs 7.24% net margin).
•APO grew revenue faster over the past five years (37.15% vs 10.16% CAGR).
•APO pays the higher dividend yield (1.56% vs 0.59%).

Which is better, APO or REGN?

Metric tally: APO 8 · REGN 6

It depends on what you're optimizing for:

ValueREGN(lower P/E)

GrowthAPO(faster 5Y revenue CAGR)

IncomeAPO(higher dividend yield)

QualityREGN(higher ROIC)

Metrics side by side

Valuation

Metric	APO	REGN
P/E ratio	40.08	14.92●
Forward P/E	14.99	11.30●
P/S ratio	2.68●	4.42
P/B ratio	3.99	2.10●
PEG ratio	0.53●	3.38
EV / EBITDA	—	11.43
FCF yield	—	6.30%

Profitability

Metric	APO	REGN
Gross margin	89.33%●	84.55%
Operating margin	31.05%●	24.32%
Net margin	7.24%	29.65%●
ROE	10.78%	14.08%●
ROIC	7.24%	8.51%●

Dividends

Metric	APO	REGN
Dividend yield	1.56%●	0.59%
Payout ratio	28.63%	8.45%

Growth (annualized)

Metric	APO	REGN
Revenue CAGR (5Y)	37.15%●	10.16%
EPS CAGR (5Y)	75.44%●	5.70%
FCF CAGR (5Y)	—	15.42%
Total return CAGR (5Y)	21.35%●	3.16%

Frequently asked

Which is better, APO or REGN?: It depends on your goal. value: REGN (lower P/E); growth: APO (faster 5Y revenue CAGR); income: APO (higher dividend yield); quality: REGN (higher ROIC). Across all compared metrics, APO leads 8 to 6.
Is APO or REGN cheaper?: On trailing earnings, REGN is cheaper: APO trades at a 40.08 P/E and REGN at 14.92.
Which has grown faster, APO or REGN?: Over the past five years, APO grew revenue faster — APO at a 37.15% CAGR versus REGN at 10.16%.
Does APO or REGN pay a bigger dividend?: APO yields 1.56% and REGN yields 0.59% based on trailing dividends and the latest price.
Is APO or REGN more profitable?: REGN runs the higher net margin — APO at 7.24% versus REGN at 29.65%.
Which has been the better investment, APO or REGN?: Over the past 10-year, APO delivered the higher annualized total return — APO at 29.59% versus REGN at 5.30%. Past performance doesn't predict future results.

Go deeper

Full APO analysis Full REGN analysis Interactive comparison tool

Dig into the metrics

Apollo Global Management P/E ratio Regeneron Pharmaceuticals P/E ratio Apollo Global Management dividend yield Regeneron Pharmaceuticals dividend yield Apollo Global Management ROE Regeneron Pharmaceuticals ROE Apollo Global Management operating margin Regeneron Pharmaceuticals operating margin Apollo Global Management revenue growth Regeneron Pharmaceuticals revenue growth Apollo Global Management free cash flow Regeneron Pharmaceuticals free cash flow

Apollo Global Management & Regeneron Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 15, 2026.